Oncology Biotech Co. Secures $145M In Funding
Henderson, Nevada-headquartered Secura Bio Inc., a company focused on commercializing oncology therapies, has received $145 million in equity and debt financing from private investment firm Athyrium Capital Management LP, the companies...To view the full article, register now.
Already a subscriber? Click here to view full article